SKA3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.13713549266504E-14 |
Normal-vs-Stage2 |
3.40289999956056E-07 |
Normal-vs-Stage3 |
4.7027937100097E-12 |
Normal-vs-Stage4 |
3.31090044269899E-10 |
Stage1-vs-Stage2 |
8.057600E-01 |
Stage1-vs-Stage3 |
1.568300E-02 |
Stage1-vs-Stage4 |
8.43249999999962E-05 |
Stage2-vs-Stage3 |
1.035440E-01 |
Stage2-vs-Stage4 |
4.231900E-04 |
Stage3-vs-Stage4 |
9.941600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
<1E-12 |
Normal-vs-AfricanAmerican |
1.166660E-04 |
Normal-vs-Asian |
1.700220E-01 |
Caucasian-vs-AfricanAmerican |
8.40380000000085E-05 |
Caucasian-vs-Asian |
5.737800E-01 |
AfricanAmerican-vs-Asian |
3.288400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62436730732907E-12 |
Normal-vs-Female |
1.67266200890026E-12 |
Male-vs-Female |
3.026400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.399500E-04 |
Normal-vs-Age(41-60Yrs) |
1.62492241884138E-12 |
Normal-vs-Age(61-80Yrs) |
1.63491442606301E-12 |
Normal-vs-Age(81-100Yrs) |
6.16430000000001E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.871000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.116400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.034400E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.180200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.477800E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.802100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.989700E-04 |
Normal-vs-Grade 2 |
7.80486786311485E-14 |
Normal-vs-Grade 3 |
<1E-12 |
Normal-vs-Grade 4 |
3.11190000434891E-08 |
Grade 1-vs-Grade 2 |
8.438700E-03 |
Grade 1-vs-Grade 3 |
1.185580E-04 |
Grade 1-vs-Grade 4 |
3.92510000000179E-05 |
Grade 2-vs-Grade 3 |
1.642380E-02 |
Grade 2-vs-Grade 4 |
9.407500E-04 |
Grade 3-vs-Grade 4 |
9.219500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.64868119156836E-12 |
Normal-vs-ccB subtype |
4.8132609009599E-12 |
ccA subtype-vs-ccB subtype |
8.444900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.11022302462516E-16 |
Normal-vs-N1 |
6.30289999999922E-05 |
N0-vs-N1 |
7.516300E-03 |
|
|